Microbix and Oneworld Create COVID-19 Test Quality Program

Logo-2_large.png

Microbix Biosystems Inc. and Oneworld Accuracy have announced a collaboration to provide a global external quality assessment (EQA) program to support clinically-effective COVID-19 testing. The program will be first launched in Canada and, as production scales, will be rolled out worldwide.

logo.png

Microbix will provide all EQA samples for the program. Oneworld will manage all informatics and logistics.

Previous
Previous

Spartan Bioscience Receives Health Canada Approval for Fast, Portable COVID-19 Test

Next
Next

Mobio Interactive Teams Up With Hospitals to Provide COVID-19 Mental Health Support